Product Name
Malcavernin (CCM2), Polyclonal Antibody
Popular Item
Full Product Name
Anti-Malcavernin Antibody
Product Synonym Names
C7orf22; Malcavernin; Cerebral cavernous malformations 2 protein
Product Gene Name
anti-CCM2 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for Q9BSQ5
Species Reactivity
Human, Mouse, Rat
Specificity
Recognizes endogenous levels of Malcavernin protein.
Purity/Purification
The antibody was purified by immunogen affinity chromatography.
Form/Format
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Immunogen
Recombinant full length protein of human Malcavernin
Preparation and Storage
Shipped at 4 degree C. Upon delivery aliquot and store at -20 degree C for one year. Avoid freeze/thaw cycles.
Other Notes
Small volumes of anti-CCM2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-CCM2 antibody
Rabbit polyclonal antibody to Malcavernin
Applications Tested/Suitable for anti-CCM2 antibody
Western Blot (WB), Immunohistochemistry (IHC)
Application Notes for anti-CCM2 antibody
WB: 1/500 - 1/2000; IHC: 1/50 - 1/200
Western Blot (WB) of anti-CCM2 antibody
Western blot analysis of Malcavernin expression in mouse brain (A), mouse testis (B) whole cell lysates.

Immunohistochemistry (IHC) of anti-CCM2 antibody
Immunohistochemical analysis of Malcavernin staining in rat heart formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

NCBI/Uniprot data below describe general gene information for CCM2. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001025006.1
[Other Products]
NCBI GenBank Nucleotide #
NM_001029835.2
[Other Products]
UniProt Primary Accession #
Q9BSQ5
[Other Products]
UniProt Secondary Accession #
Q71RE5; Q8TAT4; A4D2L4; B3KUV0; D3DVL4; E9PDJ3; F5H0E1; F5H551[Other Products]
UniProt Related Accession #
Q9BSQ5[Other Products]
Molecular Weight
42,073 Da
NCBI Official Full Name
cerebral cavernous malformations 2 protein isoform 1
NCBI Official Synonym Full Names
CCM2 scaffolding protein
NCBI Official Symbol
CCM2??[Similar Products]
NCBI Official Synonym Symbols
OSM; C7orf22; PP10187
??[Similar Products]
NCBI Protein Information
cerebral cavernous malformations 2 protein
UniProt Protein Name
Cerebral cavernous malformations 2 protein
UniProt Synonym Protein Names
Malcavernin
Protein Family
Cerebral cavernous malformations protein
UniProt Gene Name
CCM2??[Similar Products]
UniProt Synonym Gene Names
C7orf22??[Similar Products]
UniProt Entry Name
CCM2_HUMAN
NCBI Summary for CCM2
This gene encodes a scaffold protein that functions in the stress-activated p38 Mitogen-activated protein kinase (MAPK) signaling cascade. The protein interacts with SMAD specific E3 ubiquitin protein ligase 1 (also known as SMURF1) via a phosphotyrosine binding domain to promote RhoA degradation. The protein is required for normal cytoskeletal structure, cell-cell interactions, and lumen formation in endothelial cells. Mutations in this gene result in cerebral cavernous malformations. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2009]
UniProt Comments for CCM2
Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. May act through the stabilization of endothelial cell junctions (). May function as a scaffold protein for MAP2K3-MAP3K3 signaling. Seems to play a major role in the modulation of MAP3K3-dependent p38 activation induced by hyperosmotic shock ().
Research Articles on CCM2
1. a new mutation in MGC4607/CCM2 was identified in several family members with spinal and cutaneous angiomas.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.